NEUROGENE INC.
- Country
- ๐บ๐ธUnited States
- Ownership
- Private, Subsidiary
- Established
- 2003-12-01
- Employees
- 56
- Market Cap
- -
- Website
- https://www.neoleukin.com
Clinical Trials
6
Trial Phases
1 Phases
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)โข Click on a phase to view related trials
A Novel, Regulated Gene Therapy (NGN-401) Study for Females With Rett Syndrome
- Conditions
- Rett Syndrome
- First Posted Date
- 2023-06-12
- Last Posted Date
- 2025-05-23
- Lead Sponsor
- Neurogene Inc.
- Target Recruit Count
- 14
- Registration Number
- NCT05898620
- Locations
- ๐บ๐ธ
Children's Hospital Colorado, Aurora, Colorado, United States
๐บ๐ธRush University Medical Center, Chicago, Illinois, United States
๐บ๐ธBoston Children's Hospital, Boston, Massachusetts, United States
Gene Therapy Study for Children With CLN5 Batten Disease
- Conditions
- Neuronal Ceroid Lipofuscinosis CLN5
- First Posted Date
- 2022-02-08
- Last Posted Date
- 2024-08-12
- Lead Sponsor
- Neurogene Inc.
- Target Recruit Count
- 6
- Registration Number
- NCT05228145
- Locations
- ๐บ๐ธ
University of Rochester, Rochester, New York, United States
๐ฌ๐งGreat Ormond Street Hospital for Children, London, United Kingdom
NL-201 Monotherapy and in Combination With Pembrolizumab in Patients With Relapsed or Refractory Cancer
- Conditions
- Advanced Solid TumorSolid Tumor
- Interventions
- First Posted Date
- 2020-12-09
- Last Posted Date
- 2024-09-30
- Lead Sponsor
- Neurogene Inc.
- Target Recruit Count
- 59
- Registration Number
- NCT04659629
- Locations
- ๐บ๐ธ
Memorial Sloan Kettering Cancer Center, New York, New York, United States
๐บ๐ธProvidence Cancer Center Oncology and Hematology Care Clinic, Portland, Oregon, United States
๐บ๐ธUT- MD Anderson, Houston, Texas, United States
A Natural History Study of Aspartylglucosaminuria
- Conditions
- AspartylglucosaminuriaAspartylglucosamidase (AGA) DeficiencyLysosomal Storage Diseases
- First Posted Date
- 2019-02-26
- Last Posted Date
- 2022-04-12
- Lead Sponsor
- Neurogene Inc.
- Target Recruit Count
- 8
- Registration Number
- NCT03853876
- Locations
- ๐บ๐ธ
University of Texas Southwestern, Dallas, Texas, United States
A Natural History Study of Neuronal Ceroid Lipofuscinosis Type 5 (CLN5)
- Conditions
- Ceroid Lipofuscinosis, Neuronal 5
- First Posted Date
- 2019-01-30
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- Neurogene Inc.
- Target Recruit Count
- 37
- Registration Number
- NCT03822650
- Locations
- ๐บ๐ธ
University of Rochester Medical Center, Rochester, New York, United States
- Prev
- 1
- 2
- Next